Dianthus Therapeutics annual revenue
2016
2017
2018
2019
2022
2023
2024
2025
Dianthus Therapeutics Revenue Growth & History (DNTH)
Dianthus Therapeutics reported $2.0M in revenue for fiscal 2025, a decrease of 67.35% from the previous fiscal year.
View full Dianthus Therapeutics company overviewDianthus Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.0M | −$4.2M | −67.35% |
| 2024 | 2024-12-31 | $6.2M | $3.4M | +120.63% |
| 2023 | 2023-12-31 | $2.8M | −$3.6M | −55.96% |
| 2022 | 2022-12-31 | $6.4M | — | — |
| 2019 | 2019-12-31 | $0 | $0 | — |
| 2018 | 2018-12-31 | $0 | $0 | — |
| 2017 | 2017-12-31 | $0 | $0 | — |
| 2016 | 2016-12-31 | $0 | — | — |
Dianthus Therapeutics quarterly revenue
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q3.22
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $761,000 | $568,000 | +294.30% |
| Q1 2026 | 2026-03-31 | $463,000 | −$700,000 | −60.19% |
| Q4 2025 | 2025-12-31 | $284,000 | −$1.0M | −78.58% |
| Q3 2025 | 2025-09-30 | $396,000 | −$1.8M | −81.77% |
| Q2 2025 | 2025-06-30 | $193,000 | −$1.7M | −89.64% |
| Q1 2025 | 2025-03-31 | $1.2M | $289,000 | +33.07% |
| Q4 2024 | 2024-12-31 | $1.3M | — | — |
| Q3 2024 | 2024-09-30 | $2.2M | $1.2M | +135.06% |
| Q2 2024 | 2024-06-30 | $1.9M | — | — |
| Q1 2024 | 2024-03-31 | $874,000 | — | — |
| Q3 2023 | 2023-09-30 | $924,000 | −$249,000 | −21.23% |
| Q3 2022 | 2022-09-30 | $1.2M | — | — |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q2 2020 | 2020-06-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $0 | $0 | — |
| Q4 2019 | 2019-12-31 | $0 | $0 | — |
| Q3 2019 | 2019-09-30 | $0 | $0 | — |
| Q2 2019 | 2019-06-30 | $0 | $0 | — |
| Q1 2019 | 2019-03-31 | $0 | $0 | — |
| Q4 2018 | 2018-12-31 | $0 | $0 | — |
| Q3 2018 | 2018-09-30 | $0 | $0 | — |
| Q2 2018 | 2018-06-30 | $0 | $0 | — |
| Q1 2018 | 2018-03-31 | $0 | $0 | — |
| Q4 2017 | 2017-12-31 | $0 | — | — |
| Q3 2017 | 2017-09-30 | $0 | — | — |
| Q2 2017 | 2017-06-30 | $0 | — | — |
| Q1 2017 | 2017-03-31 | $0 | — | — |
Dianthus Therapeutics revenue growth trends
Dianthus Therapeutics's latest reported quarter, Q2 2026, generated $761,000 in revenue, an increase of 294.30% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Dianthus Therapeutics source filings ↗